This Institutional National Research Service Award is designed to develop skilled investigators who will pursue research-oriented careers directed at solving basic and clinical problems related to lung diseases. Training spans a variety of disciplines, including molecular and cell biology, immunology, microbiology, toxicology, biochemistry, pulmonary and critical care medicine, and neonatology. Pre-doctoral students who have demonstrated an interest in lung research will be accepted for training through Graduate Education in Biomedical Sciences (GEBS) Clusters, after they have passed their preliminary examinations. Support will begin after the second year of graduate training, and will continue for approximately three years, leading to a thesis and Ph.D. degree related to lung diseases. Post-doctoral M.D. training candidates will be accepted after completion of their subspecialty clinical training, based on a high likelihood of pursuing a research oriented career. Post-doctoral M.D.s come from residency programs in adult and pediatric pulmonology, neonatology, immunology, and infectious diseases. Post-doctoral students with the Ph.D. degree who have developed skills applicable to lung research are also candidates for training. Didactic courses, seminars, and conferences, including instruction in research ethics, will supplement the major commitment to direct research experie'nce. Trainees will develop research protocols with close supervision by their sponsors, and a committee from the interdisciplinary faculty with expertise in appropriately related fields. Training will-take place in laboratories in the clinical and basic science departments and institutes at the University of Rochester School of Medicine and Dentistry. Faculty have laboratories studying a wide range of topics suitable for training. Major research themes include lung immunology and inflammation, the molecular basis of lung injury, effects of gaseous and particulate air pollution, and airway production of nitric oxide, and mechanisms leading to pulmonary fibrosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL066988-03
Application #
6663244
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2001-09-01
Project End
2006-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
3
Fiscal Year
2003
Total Cost
$409,669
Indirect Cost
Name
University of Rochester
Department
Internal Medicine/Medicine
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Schmidt, Rachel A; Morrell, Craig N; Ling, Frederick S et al. (2018) The platelet phenotype in patients with ST-segment elevation myocardial infarction is different from non-ST-segment elevation myocardial infarction. Transl Res 195:1-12
Judge, Jennifer L; Nagel, David J; Owens, Kristina M et al. (2018) Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol. PLoS One 13:e0197936
Jones, Kyle M; Pagel, Mark D; Cárdenas-Rodríguez, Julio (2018) Linearization improves the repeatability of quantitative dynamic contrast-enhanced MRI. Magn Reson Imaging 47:16-24
Lachant, Daniel J; Meoli, David F; Haight, Deborah et al. (2018) Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats. Exp Lung Res 44:51-61
Duffney, Parker F; McCarthy, Claire E; Nogales, Aitor et al. (2018) Cigarette smoke dampens antiviral signaling in small airway epithelial cells by disrupting TLR3 cleavage. Am J Physiol Lung Cell Mol Physiol 314:L505-L513
Duffney, Parker F; Falsetta, Megan L; Rackow, Ashley R et al. (2018) Key roles for lipid mediators in the adaptive immune response. J Clin Invest 128:2724-2731
Boule, Lisbeth A; Burke, Catherine G; Jin, Guang-Bi et al. (2018) Aryl hydrocarbon receptor signaling modulates antiviral immune responses: ligand metabolism rather than chemical source is the stronger predictor of outcome. Sci Rep 8:1826
Lacy, Shannon H; Woeller, Collynn F; Thatcher, Thomas H et al. (2018) Activated Human Lung Fibroblasts Produce Extracellular Vesicles with Anti-Fibrotic Prostaglandins. Am J Respir Cell Mol Biol :
Kim, Nina; Lannan, Katie L; Thatcher, Thomas H et al. (2018) Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression. J Immunol 201:3343-3351
Cameron, Scott J; Mix, Doran S; Ture, Sara K et al. (2018) Hypoxia and Ischemia Promote a Maladaptive Platelet Phenotype. Arterioscler Thromb Vasc Biol 38:1594-1606

Showing the most recent 10 out of 159 publications